China Spinal Surgery Devices Market Size

China Spinal Surgery Devices Market Analysis

The China spinal surgery devices market is expected to register a CAGR of 3.1% over the forecast period.

The outbreak of the COVID-19 pandemic has pushed the medical device industry into action, with a race to develop both therapeutic and preventive devices in China. Exponentially increasing cases of the coronavirus in China are leading to the need for the development of novel treatments, with several clinical trials underway. Meanwhile, the manufacturers of medical devices were highly focused on developing vaccines and drugs, which can also be applied in the diagnosis and treatment of COVID-19, increasing the rate of clinical trials to a great extent. The outbreak of the pandemic adversely impacted the market in China. Most spine surgeons suffered from COVID-19 owing to which the majority of the surgical procedures were delayed or canceled. For instance, as per the study titled, "Safe Spine Surgery During the COVID-19 Pandemic" published in April 2021, the rates of COVID-19 infection among orthopedic surgeons in China were as high as 20.0%. However, increasing cases of obesity during lockdown postively impacted the market, as obesity is one of the major factors for triggering the degenerative spinal conditions. For instance, as per the study titled, "Obesity and activity patterns before and during COVID-19 lockdown among youths in China" published in October 2020, prior to COVID-19, the mean body mass index (BMI) of all youths was 21.8 kg/m2, with the prevalence of overweight/obesity and obesity being 21.3% and 10.5%, respectively. But within the month of COVID-19 lockdown, BMI has significantly increased in overall youths and the prevalence of overweight/obesity has significantly increased in China. Therefore, such instances indicate that the market witnessed a moderate growth during the pandemic.

The increasing Incidences of obesity, diabetes, and degenerative spinal conditions and increasing adoption rate of minimally invasive spinal surgeries are the major factors driving the market growth over the forecast period. For instance, according to the report published by the International Diabetes Federation in November 2021, around 140,869.6 people are living with diabetes in China age groups ranging from 20 to 79 years. It also reported that the prevalence rate of diabetes in China was around 10.6% in 2021, whereas in 2011 it was around 8.8%. Furthermore, it also reported that around 72,839.5 people were living with undiagnosed diabetes in 2021. The people living with diabetes are of greater risk of developing painful disc degeneration in the lower back. Thus, increasing cases of diabetes may increase the cases of the spinal disorders. Furthermore, as per the study titled, "Prevalence, Incidence, and External Causes of Traumatic Spinal Cord Injury in China: A Nationally Representative Cross-Sectional Survey" published in January 2022, It is estimated that around 759,302 prevalent patients with traumatic spinal cord injury and 66,374 new traumatic spinal cord injury cases were detected annually in China. Therefore, such instances are anticipated to propel the demand of spinal surgery devices in China, thereby boosting the market growth over the forecast period.

However, expensive treatment procedures is anticipated to hinder the market growth over the forecast period.